Two Sigma Advisers
TXG icon

Two Sigma Advisers’s 10x Genomics TXG Stock Holding History

Two Sigma Advisers’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,264,900
Closed -$20.6M – 2016
2025
Q4 		$20.6M Buy
1,264,900
+65,000
+5% +$982K 0.04% 345
2025
Q3 		$14M Sell
1,199,900
-614,700
-34% -$8.01M 0.03% 411
2025
Q2 		$21M Buy
1,814,600
+69,800
+4% +$636K 0.04% 328
2025
Q1 		$15.2M Buy
1,744,800
+508,600
+41% +$6.41M 0.03% 404
2024
Q4 		$17.8M Buy
1,236,200
+873,200
+241% +$13.8M 0.04% 348
2024
Q3 		$8.2M Buy
363,000
+141,700
+64% +$2.93M 0.02% 543
2024
Q2 		$4.3M Buy
221,300
+198,800
+884% +$5.21M 0.01% 828
2024
Q1 		$844K Buy
+22,500
New +$989K ﹤0.01% 1655
2023
Q3 		– Sell
-21,500
Closed -$1.2M – 2579
2023
Q2 		$1.2M Buy
+21,500
New +$1.16M ﹤0.01% 1462
2023
Q1 		– Sell
-7,100
Closed -$259K – 2754
2022
Q4 		$259K Sell
7,100
-38,300
-84% -$1.25M ﹤0.01% 2115
2022
Q3 		$1.29M Buy
+45,400
New +$1.73M ﹤0.01% 1395
2021
Q2 		– Sell
-93,700
Closed -$17M – 2703
2021
Q1 		$17M Buy
93,700
+86,300
+1,166% +$14.9M 0.05% 401
2020
Q4 		$1.05M Buy
+7,400
New +$1.07M ﹤0.01% 1547

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Advisers's TXG Position: Q1 2026 in Review

Two Sigma Advisers sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 1,264,900 shares — an estimated $20.6M sold.

Two Sigma Advisers first reported a position in TXG in Q4 2020 and held it in 13 quarters. The position peaked at $21M in Q2 2025. 331 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Two Sigma Advisers reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,264,900 10x Genomics shares in Q1 2026, an estimated $20.6M.
  • Two Sigma Advisers first reported a position in 10x Genomics in Q4 2020 and held it in 13 quarters.
  • Two Sigma Advisers's 10x Genomics position peaked at $21M in Q2 2025.
  • 331 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.